Company / Shareholders' Equity
UTAH MEDICAL PRODUCTS INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$119.3M
FY2025
5-year range
$107.1M / $119.3M
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has increased for 3 consecutive years, from $107M in FY2022 to $119M in FY2025.
Based on SEC 10-K filings.
$119M in FY2025 with a 5-year CAGR of +3.0%.
Improved from $114M to $119M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- UTAH MEDICAL PRODUCTS INC's shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +3.0%, indicating consistent growth.
- In FY2025, shareholders' equity increased 1.6% year-over-year.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $119.3M | +1.6% |
| FY2024 | $117.4M | +2.8% |
| FY2023 | $114.3M | +6.6% |
| FY2022 | $107.1M | +0.0% |
| FY2021 | $107.1M | +4.2% |
| FY2020 | $102.8M | +1.7% |
| FY2019 | $101.1M | +13.6% |
| FY2018 | $89.0M | +13.9% |
| FY2017 | $78.1M | +21.0% |
| FY2016 | $64.6M | +6.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026